Srimathy Sriskantharajah (BSc in Microbiology (UCL) and a PhD in environmental microbiology/ atmospheric chemistry (Royal Holloway University of London): Conducting research on Earth is challenging enough for most of us, but what if your research specialty is studying organisms in space?
From James Vitale, Marketing Program Director: Part I: Participants and Presentations This is the first of a three-part recap of Navigating the Challenges of Studying the Microbiome in Mouse Models: Design, Execution and Utility, a sponsored workshop at the 2017 Translational Microbiome Conference.
By Jennifer Sun, MD, MPH August 4, 2017: When I was an intern rotating through the emergency department, my attending assigned me a patient who had just arrived complaining of blood in his stool.
By James MacDonald. Dr. McDonald received a BS in Environmental Biology from Columbia and a PhD in Ecology and Evolution from Rutgers University, spending 4 years in Central America collecting data on fish in mangrove forests:
Texas A&M College of Medicine researcher found his passion and a way to transform medicine by studying the universe of microbes that live with us.
Daniel P. Haeusser is an Assistant Professor in the Biology Department of Canisius College in Buffalo, New York: In place of a weekly sermon this month, my church is having members give TED-style talks in their fields of expertise.
Response from: Philip J. Gregory, PharmD, Associate Professor, Pharmacy Practice, Center for Drug Information & Evidence-Based Practice, Creighton University, Omaha, Nebraska:
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS): Conditions that represent some of the leading causes of mortality worldwide—including obesity, diabetes, cardiovascular disease, and cancers
Paul A. Offit (…director of the Vaccine Education Center at the Children’s Hospital of Philadelphia and the author of Pandora’s Lab: Seven Stories of Science Gone Wrong [National Geographic Press, 2017]): Scientists recently found something remarkable in the microbiomes of human twins and mice with a filthy habit.
Laura Brown: Despite researchers’ best efforts, a definite cure has yet to be found for either Parkinson’s or Alzheimer’s disease. Over the last decade, the brain has been the focal point for the origin of these diseases, but scientists are now turning their attention to elsewhere
Ben Libberton, Postdoc and Public Information Officer, Karolinska Institute…researcher at the Swedish Medical Nanoscience Center in Stockholm. New research from Elisabeth Grice and Phillip Scott at the University of Pennsylvania has shown that dysbiosis in the skin of lab mice was transimissible and promoted higher levels of skin inflammation.
Three years ago, Taconic Biosciences and the University of Copenhagen came together to sponsor an Industrial PhD student through a program supported by Innovation Fund Denmark (IFD). IFD invests in new knowledge and technology creating growth and employment in Denmark.
Silvio D. Pitlik and Omry Koren: We hypothesize that probably every illness of holobionts is characterized by some perturbation of the microbiome/microbiota into a pathobiome.
SUMMARY: The Florence Statement on Triclosan and Triclocarban documents a consensus of more than 200 scientists and medical professionals on the hazards of and lack of demonstrated benefit from common uses of triclosan and triclocarban.
Trevor Lawley and Gordon Dougan are bug hunters, albeit not the conventional kind.
Eric J. Topol, MD; Ed Yong, MPhil, DISCLOSURES : Eric J. Topol, MD: Hello. I am Eric Topol. I am editor-in-chief of Medscape. I am really privileged today to have Ed Yong with me,
By Candida Fink, MD: Can the bacterial community that lives in your gut actually be related to psychiatric illnesses such as schizophrenia and bipolar disorder?
Nelly Amenyogbe, Tobias R. Kollmann and Rym Ben-Othman: Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system.
Where is the microbiome-based therapeutics market headed? A Charles River Think Tank explores the possibilities for changing how we treat disease.
Thursday, June 8, 2017 at 11 a.m. ET/5 p.m. CET Presented by: Kenneth Klingenberg Barfod, cand.scient.bio, PhD at National Research Centre for the Working Environment